Literature DB >> 17516896

Diabetes in the Torres Strait Islands of Australia: better clinical systems but significant increase in weight and other risk conditions among adults, 1999-2005.

Robyn A McDermott1, Bradley G McCulloch, Sandra K Campbell, Dallas M Young.   

Abstract

OBJECTIVES: To (i) assess changes in clinical indicators of adults diagnosed with diabetes and (ii) estimate changes in risk factors and incidence of diabetes among adults without diabetes living in the Torres Strait and Northern Peninsula Area Health Service District in Queensland from 1999 to 2005. DESIGN AND PARTICIPANTS: (i) Annual audit of clinical records of Torres Strait Islander adults on diabetes registers in 21 primary care clinics, and (ii) a 5-year follow up of a community cohort of 207 Torres Strait Islander adults without diabetes who participated in the Well Person's Health Check in 2000-01 and 2005-06. MAIN OUTCOME MEASURES: Weight, height, waist circumference, fasting blood sugar (those without diabetes) and glycated haemoglobin (HbA1c; those with diabetes) levels, blood pressure (BP), fasting triglyceride and high-density lipoprotein cholesterol levels, urinary albumin-to-creatinine ratio and smoking status.
RESULTS: The number of adults included on the diabetes register increased from 555 in 1999 to 1024 in 2005. The mean age of patients diagnosed with diabetes decreased from 53.3 to 51.5 years, and their mean weight increased from 86.8 kg to 95.6 kg. Mean HbA1c level remained unchanged at about 9%, but the proportion with HbA1c level < 7% increased from 18.4% to 26.1%, and the proportion prescribed insulin increased from 14% in 2002 to 22% in 2005. The proportion with BP < 140/90 mmHg increased from 40.3% in 1999 to 66.8% in 2005. In the sample of 207 adults without diabetes, from 2000 to 2006, there was a weight gain of about 1 kg per person per year, and an annual increase in waist circumference of 0.8 cm in men and 1.2 cm in women. Crude incidence of diabetes was 29 (95% CI, 19-41) per 1000 person-years. There was a significant increase in diastolic blood pressure and fasting blood sugar levels, and no change in smoking habits.
CONCLUSIONS: Clinical care of adults with diabetes has improved and more people with diabetes are being diagnosed. However, weight gain and high rates of glycaemia remain a challenge and will result in a large burden of complications, including renal failure. Incidence data from this sample extrapolate to 120 (95% CI, 103-147) new cases of diabetes in the District each year. Urgent action to improve nutrition, decrease smoking and increase physical activity is required to improve metabolic fitness in younger people.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516896

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  10 in total

1.  Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians.

Authors:  Matthew T Haren; Ming Li; John Petkov; Robyn A McDermott
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

2.  Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; Kerry Hunt; Daniel McAullay; Stephen A P Chubb; Brett A Sillars; David G Bruce; Wendy A Davis
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

3.  Characteristics of Indigenous adults with poorly controlled diabetes in north Queensland: implications for services.

Authors:  David Ross Johnson; Robyn Anne McDermott; Peter Marshall Clifton; Katina D'Onise; Sean Matthew Taylor; Cilla Louise Preece; Barbara Anne Schmidt
Journal:  BMC Public Health       Date:  2015-04-03       Impact factor: 3.295

4.  Concordance between administrative health data and medical records for diabetes status in coronary heart disease patients: a retrospective linked data study.

Authors:  Lee Nedkoff; Matthew Knuiman; Joseph Hung; Frank M Sanfilippo; Judith M Katzenellenbogen; Tom G Briffa
Journal:  BMC Med Res Methodol       Date:  2013-10-01       Impact factor: 4.615

5.  Barriers to insulin treatment among Australian Torres Strait Islanders with poorly controlled diabetes.

Authors:  Sean Taylor; Fintan Thompson; Robyn McDermott
Journal:  Aust J Rural Health       Date:  2016-09-08       Impact factor: 1.662

Review 6.  A scoping review of Aboriginal and Torres Strait Islander health promotion programs focused on modifying chronic disease risk factors.

Authors:  Karla J Canuto; Edoardo Aromataris; Teresa Burgess; Carol Davy; Andrea McKivett; Kate Schwartzkopff; Kootsy Canuto; Catalin Tufanaru; Craig Lockwood; Alex Brown
Journal:  Health Promot J Austr       Date:  2019-12-09

7.  Reported sources of health inequities in Indigenous Peoples with chronic kidney disease: a systematic review of quantitative studies.

Authors:  Tania Huria; Suzanne G Pitama; Lutz Beckert; Jaquelyne Hughes; Nathan Monk; Cameron Lacey; Suetonia C Palmer
Journal:  BMC Public Health       Date:  2021-07-23       Impact factor: 3.295

8.  Getting better at chronic care in remote communities: study protocol for a pragmatic cluster randomised controlled of community based management.

Authors:  Barbara Schmidt; Mark Wenitong; Adrian Esterman; Wendy Hoy; Leonie Segal; Sean Taylor; Cilla Preece; Alex Sticpewich; Robyn McDermott
Journal:  BMC Public Health       Date:  2012-11-21       Impact factor: 3.295

9.  Clinical trials in a remote Aboriginal setting: lessons from the BOABS smoking cessation study.

Authors:  Julia V Marley; Tracey Kitaura; David Atkinson; Sue Metcalf; Graeme P Maguire; Dennis Gray
Journal:  BMC Public Health       Date:  2014-06-10       Impact factor: 3.295

10.  Quality improvement in practice: improving diabetes care and patient outcomes in Aboriginal Community Controlled Health Services.

Authors:  Alice Stoneman; David Atkinson; Maureen Davey; Julia V Marley
Journal:  BMC Health Serv Res       Date:  2014-10-07       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.